AzTrials
AzTrials

Quality Assurance of Patient SafetySafe-SCOPENCT03117088

Safe-SCOPE Pilot Study

A study testing Checklist ISBAR3 and Checklist VICUR in people with Quality Assurance of Patient Safety, run by RWTH Aachen University at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Study Title Safe- SCOPE Pilot Study Standardized Checklist of Patient Information Exchange Short Title Safe- SCOPE Pilot Study Study Design: Single centre two armed cluster randomised crossover pilot study Study duration: 5 months Objectives: Influence of standardised checklists on medical/ physician handovers on an… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Quality Assurance of Patient Safety
What is being tested?
Checklist ISBAR3 and Checklist VICUR
Type of treatment
Vaccines
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
7 participants
Where
1 siteGermany
Study dates
1 Jun 2017to 30 Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Physicians:
  • all physicians working on ICU (department of Intensive Medicine and Intermediate Care) during data collection
  • existing written consent
  • Patients:
  • All patients treated in the department of Intensive Care Medicine and Intermediate Care (OIM) during assessment period who passed at least two online form based handovers

Who cannot join

  • Physicians:
  • missing written consent
  • Chief of the department of Intensive Care medicine and Intermediate Care
  • Colleagues involved in Safe- SCOPE Pilot Study protocol or group of experts
  • Patients:
  • Age < 18 years
  • Pregnancy
  • ward shift within OIM and hereby associated cluster change

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • RWTH Aachen University

    Aachen, North Rhine-Westphalia, 52074

Other trials in Germany

About this study

Official title: Safe-SCOPE Pilot Study: Standardized Checklist Of Patient Information Exchange

Study Title Safe- SCOPE Pilot Study Standardized Checklist of Patient Information Exchange

Short Title Safe- SCOPE Pilot Study

Read more

Study Design: Single centre two armed cluster randomised crossover pilot study

Study duration: 5 months

Objectives:

  • Influence of standardised checklists on medical/ physician handovers on an Intensive Care Unit -ICU and its influence on patient safety
  • Satisfaction survey in physicians group

Number of patients:

All patients treated on OIM during assessment period

Checklist Intervention

  • All physicians working in the department of Intensive Care Medicine and Intermediate Care are informed and enlightened about Safe-SCOPE Pilot Study. After written consent participating physicians will use an online form ISBAR3 Checklist or alternative Checklist for handovers twice a day.
  • Handover times/schedule:

OIM 1,2,3,5, und 6: 7:30 am and 7:30 pm OIM 4 und WEA 1: 7:30 am and 2:00 pm

  • ISBAR3 Checklist
  • VICUR Checklist wash- out Phase:
  • No checklists for one month

Efficacy:

Patients:

  • Mortality rate
  • Duration on ICU
  • Reuptake on ICU
  • SOFA Score on admission to ICU, 48h, 72h and 120h after admission
  • Handover duration per patient
  • Number of enclosed patients

Handover:

  • Entire handover duration
  • Interruptions during handover
Read the detailed description

The simplest definition of patient safety is the prevention of errors and adverse events to patient associated with health care. While health care has become more effective it has also become more complex, with greater use of new technologies, medicines and treatments. Health services treat older and sicker patients who often present with significant co- morbidities requiring more and more difficult decisions as to health care priorities.

European data, mostly from European Union Member States, consistently show that medical errors and health care related adverse events occur in 8-12% of hospitalization. For example, the United Kingdom Department of health, in its 2000 report "An organisation with a memory", estimated about 850 000 adverse events a year (10% of hospital admissions). Spain (in its 2005 national study of adverse events) and France and Denmark have published incidence studies with similar results.

While 23% of European Union citizens claim to have been directly affected by medial errors, 18% claim to have experienced a serious medical error in a hospital and 11% to be prescribed wrong medication. Evidence on medial errors shows that 50% to 70,2% of such harm can be prevented through comprehensive systematic approaches to patient safety.

Statistics of the World Health Organisation (WHO) show further more that strategies to reduce the rate of adverse events in the European Union alone would lead to the prevention of more than 750 000 harm-inflicted medial errors per year, leading in turn to over 3,2 million fewer days of hospitalization, 260 000 fewer incidents of permanent disability, and 95 000 fewer deaths per years. Our working group clarifies this as very impressive data and statistics.

In aviation checklists are an established instrument to avoid adverse events and so to improve safety. Like in the cockpit also in operating room checklists and briefings can be useful to reduce perceived risks and improve collaboration among operating rooms personnel by controlling safety standards, availability of required sources and responsibility assignment. The World Health Organisation WHO in 2009 established checklist (Save Surgery Saves Lives) is a feasible task increasingly used with individual adaptation. The Implementation has to be ingrained in a hospital wide safety culture with patient safety- related behaviour and perceived personal empowerment. The safe surgery saves lives campaign showed in eight hospitals worldwide with different socio- ecological backgrounds that in around 8. 000 operations mortality and infections rate decreased significantly after using the safe surgery saves lives checklist in operating theatres.

Checklists are efficient working tools used as a reminder or to structure processes. They guarantee that processes are objective and reproducible and therefore increase patient- safety. Especially in stress and emergency situations as they exist on an Intensive Care Unit checklists can help to avoid mind mistakes and demonstrate possible decisions.

Related to these data and statistics and on that important background we are planning a multi-centre main trial on improving patient safety: Standardized Checklist of Patient Information Exchange. Because there is no information about the magnitude of checklist effects on patient data and there is no risk for the patients we use the Safe SCOPE Pilot study to estimate the effects size of the checklists and to investigate the feasibility of the main trial.

Being tested
Checklist ISBAR3, Checklist VICUR
Keywords
Standardized handover, Online-based, SOFA-Score, ICU, ISBAR3

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Checklist ISBAR3Other

    Checklist ISBAR 3

    Use of an online based checklist for handovers with the following items:

    Identification Situation Background Assessment Recommendation Read- back Risk

    Established Checklist as communication tool

  • Checklist VICUROther

    Checklist Vicur

    Use of an online based alternative checklist for handovers with the following items:

    Vaccination status Insurance status Contact person Utilisation Rehabilitation Organ donor? Patient decree?

    alternative checklist missing communication tool

Study groups in NCT03117088
Study groupRoleWhat they receive
Checklist ISBAR 3Active comparatoronline-based checklist for standardized handovers
Receives: Other: Checklist ISBAR3
Checklist VICURPlacebo comparatorcomparator Checklist
Receives: Other: Checklist VICUR

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of SOFA Score at hour 48

    Change of SOFA Score to baseline (admission) and 48 hours after admission

    Measured: admission and hour 48

Secondary outcomes (9)
  1. Mortality rate

    Mortality rate

    Measured: 30 days

  2. Duration on ICU

    Duration on ICU measured in days

    Measured: 30 days

  3. Reuptake on ICU

    Reuptake on ICU and transferring ward

    Measured: 30 days

  4. Handover duration patient

    Handover duration per single patient

    Measured: up to 3 months

  5. Handover duration entire

    entire handover duration

    Measured: up to 3 months

  6. Interruptions

    Interruptions during handover categories: none, < 5min, > 5min

    Measured: up to 3 months

  7. physicians satisfaction

    evaluation of satisfaction by questionnaire

    Measured: through study completion, an average of 5 months

  8. Change of SOFA Score at hour 72

    Change of SOFA Score to baseline (admission) and after 72 hours

    Measured: baseline and hour 72

  9. Change of SOFA Score at hour 120

    Change of SOFA Score to baseline (admission) and after 120 hours

    Measured: baseline and hour 120

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2017
  2. Study start1 Jun 2017
  3. Primary completion30 Nov 2017
  4. Study completion30 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
two armed cluster randomized crossover three periods prospective single centre pilot study
Masking
None (open label)
Enrolment
7 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03117088
Sponsor's protocol ID
CTCA-16-164
Acronym
Safe-SCOPE
Status last verified
Jan 2018
First submitted
14 Mar 2017
Last updated
9 Jan 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, Herbosa T, Joseph S, Kibatala PL, Lapitan MC, Merry AF, Moorthy K, Reznick RK, Taylor B, Gawande AA; Safe Surgery Saves Lives Study Group. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009 Jan 29;360(5):491-9. doi: 10.1056/NEJMsa0810119. Epub 2009 Jan 14.

    PubMed 19144931
  • Keebler JR, Lazzara EH, Patzer BS, Palmer EM, Plummer JP, Smith DC, Lew V, Fouquet S, Chan YR, Riss R. Meta-Analyses of the Effects of Standardized Handoff Protocols on Patient, Provider, and Organizational Outcomes. Hum Factors. 2016 Dec;58(8):1187-1205. doi: 10.1177/0018720816672309. Epub 2016 Oct 17.

    PubMed 27821676
  • Starmer AJ, Landrigan CP; I-PASS Study Group. Changes in medical errors with a handoff program. N Engl J Med. 2015 Jan 29;372(5):490-1. doi: 10.1056/NEJMc1414788. No abstract available.

    PubMed 25629753
  • Starmer AJ, Spector ND, Srivastava R, West DC, Rosenbluth G, Allen AD, Noble EL, Tse LL, Dalal AK, Keohane CA, Lipsitz SR, Rothschild JM, Wien MF, Yoon CS, Zigmont KR, Wilson KM, O'Toole JK, Solan LG, Aylor M, Bismilla Z, Coffey M, Mahant S, Blankenburg RL, Destino LA, Everhart JL, Patel SJ, Bale JF Jr, Spackman JB, Stevenson AT, Calaman S, Cole FS, Balmer DF, Hepps JH, Lopreiato JO, Yu CE, Sectish TC, Landrigan CP; I-PASS Study Group. Changes in medical errors after implementation of a handoff program. N Engl J Med. 2014 Nov 6;371(19):1803-12. doi: 10.1056/NEJMsa1405556.

    PubMed 25372088
  • Starmer AJ, Sectish TC, Simon DW, Keohane C, McSweeney ME, Chung EY, Yoon CS, Lipsitz SR, Wassner AJ, Harper MB, Landrigan CP. Rates of medical errors and preventable adverse events among hospitalized children following implementation of a resident handoff bundle. JAMA. 2013 Dec 4;310(21):2262-70. doi: 10.1001/jama.2013.281961.

    PubMed 24302089
  • Randmaa M, Swenne CL, Martensson G, Hogberg H, Engstrom M. Implementing situation-background-assessment-recommendation in an anaesthetic clinic and subsequent information retention among receivers: A prospective interventional study of postoperative handovers. Eur J Anaesthesiol. 2016 Mar;33(3):172-8. doi: 10.1097/EJA.0000000000000335.

    PubMed 26760400
  • Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001 Oct 10;286(14):1754-8. doi: 10.1001/jama.286.14.1754.

    PubMed 11594901
  • Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 Jul;22(7):707-10. doi: 10.1007/BF01709751. No abstract available.

    PubMed 8844239
  • Kostoff M, Burkhardt C, Winter A, Shrader S. An Interprofessional Simulation Using the SBAR Communication Tool. Am J Pharm Educ. 2016 Nov 25;80(9):157. doi: 10.5688/ajpe809157.

    PubMed 28090106
  • Yee KC, Wong MC, Turner P. "HAND ME AN ISOBAR": a pilot study of an evidence-based approach to improving shift-to-shift clinical handover. Med J Aust. 2009 Jun 1;190(S11):S121-4. doi: 10.5694/j.1326-5377.2009.tb02617.x.

    PubMed 19485859
  • Verholen N, Vogt L, Klasen M, Schmidt M, Beckers S, Marx G, Sopka S. Do Digital Handover Checklists Influence the Clinical Outcome Parameters of Intensive Care Unit Patients? A Randomized Controlled Pilot Study. Front Med (Lausanne). 2021 Apr 20;8:661343. doi: 10.3389/fmed.2021.661343. eCollection 2021.

    PubMed 33959627

Questions about this trial

What is this clinical trial studying?

A study testing Checklist ISBAR3 and Checklist VICUR in people with Quality Assurance of Patient Safety, run by RWTH Aachen University at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of SOFA Score at hour 48 (time frame: admission and hour 48). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03117088, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in